Lynwood Capital Management Inc. - BRIACELL THERAPEUTICS CORP ownership

BRIACELL THERAPEUTICS CORP's ticker is BCTX and the CUSIP is 10778Y302. A total of 28 filers reported holding BRIACELL THERAPEUTICS CORP in Q4 2021. The put-call ratio across all filers is 0.33 and the average weighting 0.2%.

Quarter-by-quarter ownership
Lynwood Capital Management Inc. ownership history of BRIACELL THERAPEUTICS CORP
ValueSharesWeighting
Q3 2023$9,890,312
-2.7%
1,582,450
-0.1%
26.01%
+102.0%
Q2 2023$10,168,497
-10.8%
1,583,878
+3.5%
12.88%
+25.2%
Q1 2023$11,398,500
+170357.6%
1,530,0000.0%10.29%
+27.9%
Q4 2022$6,687
-99.9%
1,530,000
+27.7%
8.04%
+9.4%
Q3 2022$6,733,000
+89.7%
1,198,000
+94.8%
7.35%
+85.5%
Q2 2022$3,549,000
-53.3%
615,000
-18.0%
3.96%
-51.4%
Q1 2022$7,605,000
+17.0%
750,000
-4.5%
8.16%
+31.2%
Q4 2021$6,500,000785,0006.22%
Other shareholders
BRIACELL THERAPEUTICS CORP shareholders Q4 2021
NameSharesValueWeighting ↓
Lynwood Capital Management Inc. 1,583,878$10,168,49712.88%
Redmond Asset Management, LLC 137,689$883,9630.29%
K.J. Harrison & Partners Inc 34,640$216,8910.04%
WASATCH ADVISORS LP 612,088$3,929,6050.02%
Concord Wealth Partners 15,275$98,0660.02%
Caption Management, LLC 100,000$642,0000.01%
Summit Trail Advisors, LLC 35,000$224,7000.01%
NATIXIS 90,250$579,4050.01%
TD Waterhouse Canada Inc. 12,050$90,3460.00%
SIMPLEX TRADING, LLC 39,521$2530.00%
View complete list of BRIACELL THERAPEUTICS CORP shareholders